Angion Biomedica Corp. (ANGN)
NASDAQ: ANGN
· Real-Time Price · USD
1.00
0.00 (0.00%)
At close: Jun 01, 2023, 10:00 PM
Angion Biomedica Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -11.21M | -31.93M | -17.12M | -4.54M | -6.44M | -8.99M | -9.14M | -14.24M | 14.89M | -15.7M | -17.07M | -36.69M |
Depreciation & Amortization | 278K | 599K | 297K | 48K | 241K | 290K | 232K | 228K | 223K | 217K | 206K | 155K |
Stock-Based Compensation | 517K | 1.65M | 327K | 352K | 218K | -763K | 1.4M | 31K | 2.02M | 2.18M | 2.72M | 5.12M |
Other Working Capital | n/a | -1.41M | 1.66M | 1.83M | -1.94M | 1.52M | -1.46M | -301K | -28.43M | -85K | 2.06M | 1.34M |
Other Non-Cash Items | n/a | 8.56M | 5.78M | 638K | 3.02M | -18K | -175K | -48K | -133K | -147K | -1.07M | 16.41M |
Deferred Income Tax | n/a | n/a | 16K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 4.97M | 4.39M | -4.58M | -1.46M | 1.07M | -2.22M | -1.62M | -31.36M | -1.75M | 4.69M | 2.46M |
Operating Cash Flow | -10.12M | -16.16M | -6.31M | -8.08M | -4.43M | -8.41M | -9.9M | -15.65M | -14.36M | -15.2M | -10.53M | -12.55M |
Capital Expenditures | n/a | -87K | -42K | n/a | n/a | n/a | n/a | n/a | -36K | -61K | -244K | -41K |
Cash Acquisitions | n/a | n/a | -3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 10M | 3K | -10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | 9.92M | -42K | -10M | n/a | n/a | n/a | n/a | -36K | -61K | -244K | -41K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.19M | 42.93M | 21.66M | -3.27M | -15K | -17K | -14K | -14K | 404K | 699K | -2.38M | 108.44M |
Financial Cash Flow | 10.33M | 45.62M | 24.07M | -3.27M | -15K | -17K | -14K | -14K | 404K | 699K | -2.38M | 108.44M |
Net Cash Flow | 240K | -9.73M | 14.82M | -21.27M | -4.66M | -8.23M | -9.63M | -15.75M | -13.98M | -14.58M | -13.14M | 95.85M |
Free Cash Flow | -10.12M | -16.24M | -6.35M | -8.08M | -4.43M | -8.41M | -9.9M | -15.65M | -14.4M | -15.26M | -10.78M | -12.59M |